drugset / Trial / NCT02117076
Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study will compare the safety, effectiveness and tolerability of gabapentin (Neurontin) versus gabapentin enacarbil (Horizant) as treatment restless leg syndrome.
Timeline
- Start
- 2014-04
- Primary completion
- 2016-06
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gabapentin | Small molecule | 1200 mg | — |
| Comparator | gabapentin enacarbil | Small molecule | 1200 mg | — |